[go: up one dir, main page]

IL109760A0 - Modified human tissue-type plasminogen activator which retains its biological activity and is characterized by an increased in vivo hlaf-life - Google Patents

Modified human tissue-type plasminogen activator which retains its biological activity and is characterized by an increased in vivo hlaf-life

Info

Publication number
IL109760A0
IL109760A0 IL10976094A IL10976094A IL109760A0 IL 109760 A0 IL109760 A0 IL 109760A0 IL 10976094 A IL10976094 A IL 10976094A IL 10976094 A IL10976094 A IL 10976094A IL 109760 A0 IL109760 A0 IL 109760A0
Authority
IL
Israel
Prior art keywords
hlaf
retains
vivo
life
increased
Prior art date
Application number
IL10976094A
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL88247A external-priority patent/IL88247A0/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL109760A0 publication Critical patent/IL109760A0/en

Links

IL10976094A 1987-11-06 1994-05-24 Modified human tissue-type plasminogen activator which retains its biological activity and is characterized by an increased in vivo hlaf-life IL109760A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11809887A 1987-11-06 1987-11-06
IL88247A IL88247A0 (en) 1987-11-06 1988-10-31 Novel human tissue-type plasminogen activator variant

Publications (1)

Publication Number Publication Date
IL109760A0 true IL109760A0 (en) 1994-08-26

Family

ID=26321860

Family Applications (3)

Application Number Title Priority Date Filing Date
IL10495388A IL104953A (en) 1987-11-06 1988-10-31 Method for producing tissue-type plasminogen activator by transforming and cultivating a host cell incapable of forming complex glycoproteins
IL10976094A IL109760A0 (en) 1987-11-06 1994-05-24 Modified human tissue-type plasminogen activator which retains its biological activity and is characterized by an increased in vivo hlaf-life
IL10975994A IL109759A0 (en) 1987-11-06 1994-05-24 Human tissue-type plasminogen activator having modified functional carbohydrate residues, which retains its biological activity and is characterized by an increased in vivo half-life

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL10495388A IL104953A (en) 1987-11-06 1988-10-31 Method for producing tissue-type plasminogen activator by transforming and cultivating a host cell incapable of forming complex glycoproteins

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL10975994A IL109759A0 (en) 1987-11-06 1994-05-24 Human tissue-type plasminogen activator having modified functional carbohydrate residues, which retains its biological activity and is characterized by an increased in vivo half-life

Country Status (1)

Country Link
IL (3) IL104953A (en)

Also Published As

Publication number Publication date
IL104953A (en) 2002-08-14
IL109759A0 (en) 1994-08-26

Similar Documents

Publication Publication Date Title
EG20419A (en) Improved biological insect control agents and methods of use
ES2000743A6 (en) Pharmaceutical dosage unit.
ATE109765T1 (en) N-ALKOXYALKYLAMIDES OF HYDROXY ACIDS AND SKIN TREATMENT PREPARATIONS CONTAINING THEM.
NO882792D0 (en) PREPARATION AND USE OF PROMOTERS FOR EXPRESSION OF FOREIGN DNA IN METHYLOTROPHERE BACTERIA.
NZ217331A (en) Tissue plasminogen activator derivatives and genetically engineered product
AU1892788A (en) Improvements relating to measurement of tissue plasminogen activator activity
IL90745A0 (en) Tissue plasminogen activator analogue and nucleic acid coding for it
AU589283B2 (en) Synergistic blood clot treatment composition comprising tissue plasminogen activator and a prostaglandin
IL85205A0 (en) Plasmid capable of high level expression in e. coli of soluble mature hil-1beta and derivatives with altered biological activity
IL91774A0 (en) Preparation of plasminogen activator expressed in prokaryotes
IL109760A0 (en) Modified human tissue-type plasminogen activator which retains its biological activity and is characterized by an increased in vivo hlaf-life
DK112290D0 (en) Tissue plasminogen activator VARIANT
EP0576039A3 (en) Method of determining tissue plasminogen activator activity in biological fluids
IL86887A0 (en) Improved human tissue plasminogen activator and its use
ZA862976B (en) Human tissue plasminogen activator mutants
IE872091L (en) Combination of tissue plasminogen activator and a¹prostaglandin
IE870208L (en) Modified tissue plasminogen activator
IE882534L (en) Peg complex of tissue plasminogen activator
GB8725052D0 (en) Tissue plasminogen activator
GB8718298D0 (en) Tissue plasminogen activator
GB8726683D0 (en) Tissue plasminogen activator
IE871856L (en) "modified tissue plasminogen activator"
IE883342L (en) Human tissue-type plasminogen activator variant
ZA892855B (en) Product with antibody activity agents consisting thereof and use for treatment of bacterial-or toxinrelated
ZA88554B (en) High level expression in e.coli of soluble mature hil-1beta and derivatives with altered biological activity